Blood Platelet Market By Platelet Type (Whole Blood Derived Platelets, Apheresis Derived Platelets) , By Application (Platelet Function Disorder, Hemophilia, Thrombocytopenia, Perioperative Indication) By End User (Hospitals, Ambulatory Surgical Centers, Blood Banks, Research Laboratories, Specialty Clinics, Cancer Treatment Centers, Trauma Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Blood Platelet Market Expected to Garner $9.1 Billion by 2033, Growing at a CAGR of 5.4%
The global blood platelet market is expected to grow primarily due to the rising adoption of platelet-rich plasma (PRP) therapies across medical and aesthetic fields. The North America region is predicted to witness profitable growth by 2033.
As per the report published by Research Dive, the global blood platelet market was valued at $5.4 billion in 2023 and is expected to register a revenue of $9.1 billion by 2033 at a CAGR of 5.4% during the forecast period 2024-2033.
Dynamics of the Market
The increasing demand for platelet-rich plasma (PRP) therapies across medical & aesthetic fields, growing prevalence of blood-related diseases, and the rising number of critical surgeries across the globe are expected to make the blood platelet market a highly profitable one in the forecast period. Besides, there is an increasing demand for blood platelets from hospitals, blood banks, ambulatory surgical centers, research laboratories, cancer treatment centers, and specialty clinics.
However, according to market analysts, the risk of bacterial contamination and the limited access of treatment in underdeveloped regions might restrain the growth of the market.
Advancements in healthcare technologies and the integration of personalized medicine & regenerative therapies present significant opportunities for blood platelet market growth. Moreover, advancements in biotechnology are transforming how platelets are produced and stored, creating new avenues for market growth in the coming years.
Key Players of the Market
The major players of the blood platelet market include America’s Blood Centers, Canadian Blood Services, American Association of Blood Banks (AABB), French Red Cross, Japanese Red Cross Society, European Blood Alliance, American National Red Cross, Australian Red Cross, OneBlood, and Blood Bank of Alaska.
What the Report Covers
In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).
Key Market Segments
By Platelet Type
Whole Blood Derived Platelets
Apheresis Derived Platelets
By Application
Platelet Function Disorder
Hemophilia
Thrombocytopenia
Perioperative Indication
By End User
Hospitals
Ambulatory Surgical Centers
Blood Banks
Research Laboratories
Specialty Clinics
Cancer Treatment Centers
Trauma Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
UAE
Rest of LAMEA
Key Market Players
America’s Blood Centers
American Association of Blood Banks (AABB)
Canadian Blood Services
French Red Cross
European Blood Alliance
Japanese Red Cross Society
American National Red Cross
OneBlood
Australian Red Cross
Blood Bank of Alaska
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: BLOOD PLATELET MARKET, BY PLATELET TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Platelet Type
- 4.2. Whole Blood Derived Platelets
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Apheresis Derived Platelets
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: BLOOD PLATELET MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Platelet Function Disorder
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Hemophilia
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Thrombocytopenia
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Perioperative Indication
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- CHAPTER 6: BLOOD PLATELET MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Ambulatory Surgical Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Blood Banks
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Research Laboratories
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- 6.6. Specialty Clinics
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country
- 6.7. Cancer Treatment Centers
- 6.7.1. Key Market Trends, Growth Factors and Opportunities
- 6.7.2. Market Size and Forecast, By Region
- 6.7.3. Market Share Analysis, By Country
- 6.8. Trauma Centers
- 6.8.1. Key Market Trends, Growth Factors and Opportunities
- 6.8.2. Market Size and Forecast, By Region
- 6.8.3. Market Share Analysis, By Country
- 6.9. Others
- 6.9.1. Key Market Trends, Growth Factors and Opportunities
- 6.9.2. Market Size and Forecast, By Region
- 6.9.3. Market Share Analysis, By Country
- CHAPTER 7: BLOOD PLATELET MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Platelet Type
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Blood Platelet Market
- 7.2.6.1. Market Size and Forecast, By Platelet Type
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Blood Platelet Market
- 7.2.7.1. Market Size and Forecast, By Platelet Type
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Blood Platelet Market
- 7.2.8.1. Market Size and Forecast, By Platelet Type
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Platelet Type
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Blood Platelet Market
- 7.3.6.1. Market Size and Forecast, By Platelet Type
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Blood Platelet Market
- 7.3.7.1. Market Size and Forecast, By Platelet Type
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Blood Platelet Market
- 7.3.8.1. Market Size and Forecast, By Platelet Type
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Blood Platelet Market
- 7.3.9.1. Market Size and Forecast, By Platelet Type
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Blood Platelet Market
- 7.3.10.1. Market Size and Forecast, By Platelet Type
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Blood Platelet Market
- 7.3.11.1. Market Size and Forecast, By Platelet Type
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Platelet Type
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Blood Platelet Market
- 7.4.6.1. Market Size and Forecast, By Platelet Type
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Blood Platelet Market
- 7.4.7.1. Market Size and Forecast, By Platelet Type
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Blood Platelet Market
- 7.4.8.1. Market Size and Forecast, By Platelet Type
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Blood Platelet Market
- 7.4.9.1. Market Size and Forecast, By Platelet Type
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Blood Platelet Market
- 7.4.10.1. Market Size and Forecast, By Platelet Type
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Blood Platelet Market
- 7.4.11.1. Market Size and Forecast, By Platelet Type
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Platelet Type
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Blood Platelet Market
- 7.5.6.1. Market Size and Forecast, By Platelet Type
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Blood Platelet Market
- 7.5.7.1. Market Size and Forecast, By Platelet Type
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Blood Platelet Market
- 7.5.8.1. Market Size and Forecast, By Platelet Type
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. UAE Blood Platelet Market
- 7.5.9.1. Market Size and Forecast, By Platelet Type
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- 7.5.10. Rest of LAMEA Blood Platelet Market
- 7.5.10.1. Market Size and Forecast, By Platelet Type
- 7.5.10.2. Market Size and Forecast, By Application
- 7.5.10.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. America’s Blood Centers
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. American Association Of Blood Banks (AABB)
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Canadian Blood Services
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. French Red Cross
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. European Blood Alliance
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Japanese Red Cross Society
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. American National Red Cross
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. OneBlood
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Australian Red Cross
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Blood Bank Of Alaska
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. BLOOD PLATELET MARKET FOR WHOLE BLOOD DERIVED PLATELETS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. BLOOD PLATELET MARKET FOR APHERESIS DERIVED PLATELETS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 5. BLOOD PLATELET MARKET FOR PLATELET FUNCTION DISORDER, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. BLOOD PLATELET MARKET FOR HEMOPHILIA, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. BLOOD PLATELET MARKET FOR THROMBOCYTOPENIA, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. BLOOD PLATELET MARKET FOR PERIOPERATIVE INDICATION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. GLOBAL BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 10. BLOOD PLATELET MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. BLOOD PLATELET MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. BLOOD PLATELET MARKET FOR BLOOD BANKS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. BLOOD PLATELET MARKET FOR RESEARCH LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. BLOOD PLATELET MARKET FOR SPECIALTY CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. BLOOD PLATELET MARKET FOR CANCER TREATMENT CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. BLOOD PLATELET MARKET FOR TRAUMA CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 17. BLOOD PLATELET MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 18. BLOOD PLATELET MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 19. NORTH AMERICA BLOOD PLATELET MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 20. NORTH AMERICA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 21. NORTH AMERICA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 22. NORTH AMERICA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 23. U.S. BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 24. U.S. BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 25. U.S. BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 26. CANADA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 27. CANADA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 28. CANADA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. MEXICO BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 30. MEXICO BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 31. MEXICO BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. EUROPE BLOOD PLATELET MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 33. EUROPE BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 34. EUROPE BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 35. EUROPE BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 36. FRANCE BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 37. FRANCE BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 38. FRANCE BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. GERMANY BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 40. GERMANY BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 41. GERMANY BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 42. ITALY BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 43. ITALY BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 44. ITALY BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. SPAIN BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 46. SPAIN BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 47. SPAIN BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 48. UK BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 49. UK BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 50. UK BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. REST OF EUROPE BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 52. REST OF EUROPE BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 53. REST OF EUROPE BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. ASIA-PACIFIC BLOOD PLATELET MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 55. ASIA-PACIFIC BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 56. ASIA-PACIFIC BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 57. ASIA-PACIFIC BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. CHINA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 59. CHINA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 60. CHINA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 61. JAPAN BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 62. JAPAN BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 63. JAPAN BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 64. INDIA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 65. INDIA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 66. INDIA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 67. SOUTH KOREA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 68. SOUTH KOREA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 69. SOUTH KOREA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 70. AUSTRALIA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 71. AUSTRALIA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 72. AUSTRALIA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 73. REST OF ASIA-PACIFIC BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 74. REST OF ASIA-PACIFIC BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 75. REST OF ASIA-PACIFIC BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 76. LAMEA BLOOD PLATELET MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 77. LAMEA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 78. LAMEA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 79. LAMEA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 80. BRAZIL BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 81. BRAZIL BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 82. BRAZIL BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 83. SOUTH AFRICA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 84. SOUTH AFRICA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 85. SOUTH AFRICA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 86. SAUDI ARABIA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 87. SAUDI ARABIA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 88. SAUDI ARABIA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 89. UAE BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 90. UAE BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 91. UAE BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 92. REST OF LAMEA BLOOD PLATELET MARKET, BY PLATELET TYPE, 2024 - 2033 ($BILLION)
- TABLE 93. REST OF LAMEA BLOOD PLATELET MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 94. REST OF LAMEA BLOOD PLATELET MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 95. AMERICA’S BLOOD CENTERS: KEY EXECUTIVES
- TABLE 96. AMERICA’S BLOOD CENTERS: COMPANY SNAPSHOT
- TABLE 97. AMERICA’S BLOOD CENTERS: OPERATING SEGMENTS
- TABLE 98. AMERICA’S BLOOD CENTERS: PRODUCT PORTFOLIO
- TABLE 99. AMERICA’S BLOOD CENTERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100. AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) : KEY EXECUTIVES
- TABLE 101. AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) : COMPANY SNAPSHOT
- TABLE 102. AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) : OPERATING SEGMENTS
- TABLE 103. AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) : PRODUCT PORTFOLIO
- TABLE 104. AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105. CANADIAN BLOOD SERVICES: KEY EXECUTIVES
- TABLE 106. CANADIAN BLOOD SERVICES: COMPANY SNAPSHOT
- TABLE 107. CANADIAN BLOOD SERVICES: OPERATING SEGMENTS
- TABLE 108. CANADIAN BLOOD SERVICES: PRODUCT PORTFOLIO
- TABLE 109. CANADIAN BLOOD SERVICES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 110. FRENCH RED CROSS: KEY EXECUTIVES
- TABLE 111. FRENCH RED CROSS: COMPANY SNAPSHOT
- TABLE 112. FRENCH RED CROSS: OPERATING SEGMENTS
- TABLE 113. FRENCH RED CROSS: PRODUCT PORTFOLIO
- TABLE 114. FRENCH RED CROSS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 115. EUROPEAN BLOOD ALLIANCE: KEY EXECUTIVES
- TABLE 116. EUROPEAN BLOOD ALLIANCE: COMPANY SNAPSHOT
- TABLE 117. EUROPEAN BLOOD ALLIANCE: OPERATING SEGMENTS
- TABLE 118. EUROPEAN BLOOD ALLIANCE: PRODUCT PORTFOLIO
- TABLE 119. EUROPEAN BLOOD ALLIANCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 120. JAPANESE RED CROSS SOCIETY: KEY EXECUTIVES
- TABLE 121. JAPANESE RED CROSS SOCIETY: COMPANY SNAPSHOT
- TABLE 122. JAPANESE RED CROSS SOCIETY: OPERATING SEGMENTS
- TABLE 123. JAPANESE RED CROSS SOCIETY: PRODUCT PORTFOLIO
- TABLE 124. JAPANESE RED CROSS SOCIETY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 125. AMERICAN NATIONAL RED CROSS: KEY EXECUTIVES
- TABLE 126. AMERICAN NATIONAL RED CROSS: COMPANY SNAPSHOT
- TABLE 127. AMERICAN NATIONAL RED CROSS: OPERATING SEGMENTS
- TABLE 128. AMERICAN NATIONAL RED CROSS: PRODUCT PORTFOLIO
- TABLE 129. AMERICAN NATIONAL RED CROSS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 130. ONEBLOOD: KEY EXECUTIVES
- TABLE 131. ONEBLOOD: COMPANY SNAPSHOT
- TABLE 132. ONEBLOOD: OPERATING SEGMENTS
- TABLE 133. ONEBLOOD: PRODUCT PORTFOLIO
- TABLE 134. ONEBLOOD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 135. AUSTRALIAN RED CROSS: KEY EXECUTIVES
- TABLE 136. AUSTRALIAN RED CROSS: COMPANY SNAPSHOT
- TABLE 137. AUSTRALIAN RED CROSS: OPERATING SEGMENTS
- TABLE 138. AUSTRALIAN RED CROSS: PRODUCT PORTFOLIO
- TABLE 139. AUSTRALIAN RED CROSS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 140. BLOOD BANK OF ALASKA: KEY EXECUTIVES
- TABLE 141. BLOOD BANK OF ALASKA: COMPANY SNAPSHOT
- TABLE 142. BLOOD BANK OF ALASKA: OPERATING SEGMENTS
- TABLE 143. BLOOD BANK OF ALASKA: PRODUCT PORTFOLIO
- TABLE 144. BLOOD BANK OF ALASKA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL BLOOD PLATELET MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF BLOOD PLATELET MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN BLOOD PLATELET MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBLOOD PLATELET MARKET
- FIGURE 10. GLOBAL BLOOD PLATELET MARKET SEGMENTATION, BY PLATELET TYPE
- FIGURE 11. BLOOD PLATELET MARKET FOR WHOLE BLOOD DERIVED PLATELETS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. BLOOD PLATELET MARKET FOR APHERESIS DERIVED PLATELETS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL BLOOD PLATELET MARKET SEGMENTATION, BY APPLICATION
- FIGURE 14. BLOOD PLATELET MARKET FOR PLATELET FUNCTION DISORDER, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. BLOOD PLATELET MARKET FOR HEMOPHILIA, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. BLOOD PLATELET MARKET FOR THROMBOCYTOPENIA, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. BLOOD PLATELET MARKET FOR PERIOPERATIVE INDICATION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. GLOBAL BLOOD PLATELET MARKET SEGMENTATION, BY END USER
- FIGURE 19. BLOOD PLATELET MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. BLOOD PLATELET MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. BLOOD PLATELET MARKET FOR BLOOD BANKS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. BLOOD PLATELET MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. BLOOD PLATELET MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. BLOOD PLATELET MARKET FOR CANCER TREATMENT CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 25. BLOOD PLATELET MARKET FOR TRAUMA CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 26. BLOOD PLATELET MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 31. COMPETITIVE DASHBOARD
- FIGURE 32. COMPETITIVE HEATMAP: BLOOD PLATELET MARKET
- FIGURE 33. TOP PLAYER POSITIONING, 2023
- FIGURE 34. AMERICA’S BLOOD CENTERS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. AMERICA’S BLOOD CENTERS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. AMERICA’S BLOOD CENTERS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) : NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. CANADIAN BLOOD SERVICES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. CANADIAN BLOOD SERVICES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. CANADIAN BLOOD SERVICES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. FRENCH RED CROSS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. FRENCH RED CROSS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. FRENCH RED CROSS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. EUROPEAN BLOOD ALLIANCE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. EUROPEAN BLOOD ALLIANCE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. EUROPEAN BLOOD ALLIANCE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. JAPANESE RED CROSS SOCIETY: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. JAPANESE RED CROSS SOCIETY: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. JAPANESE RED CROSS SOCIETY: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. AMERICAN NATIONAL RED CROSS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. AMERICAN NATIONAL RED CROSS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. AMERICAN NATIONAL RED CROSS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. ONEBLOOD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 56. ONEBLOOD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. ONEBLOOD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 58. AUSTRALIAN RED CROSS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 59. AUSTRALIAN RED CROSS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 60. AUSTRALIAN RED CROSS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 61. BLOOD BANK OF ALASKA: NET SALES, 2021-2023 ($BILLION)
- FIGURE 62. BLOOD BANK OF ALASKA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 63. BLOOD BANK OF ALASKA: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook